Sonnet BioTherapeutics Holdings Inc [NASDAQ: SONN] plunged by -$0.23 during the normal trading session on while it closed the day at $1.55.
Sonnet BioTherapeutics Holdings Inc stock has also gained 6.16% of its value over the past 7 days. However, SONN stock has declined by -68.24% in the 3 months of the year. Over the past six months meanwhile, it has lost -76.94% and gained 6.16% year-on date.
The market cap for SONN stock reached $4.66 million, with 3.01 million shares outstanding and 2.87 million shares in the current float. Compared to the average trading volume of 1.38M shares, SONN reached a trading volume of 270508 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Sonnet BioTherapeutics Holdings Inc [SONN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SONN shares is $20.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SONN stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Sonnet BioTherapeutics Holdings Inc is set at 0.34, with the Price to Sales ratio for SONN stock in the period of the last 12 months amounting to 232.94.
SONN stock trade performance evaluation
Sonnet BioTherapeutics Holdings Inc [SONN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.16. With this latest performance, SONN shares dropped by -26.19% in over the last four-week period, additionally sinking by -76.94% over the last 6 months – not to mention a drop of -86.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SONN stock in for the last two-week period is set at 36.27, with the RSI for the last a single of trading hit 39.83, and the three-weeks RSI is set at 34.44 for Sonnet BioTherapeutics Holdings Inc [SONN]. The present Moving Average for the last 50 days of trading for this stock 2.5810, while it was recorded at 1.7160 for the last single week of trading, and 7.8334 for the last 200 days.
Sonnet BioTherapeutics Holdings Inc [SONN]: An insightful look at the core fundamentals
Sonnet BioTherapeutics Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.66 and a Current Ratio set at 0.66.
Sonnet BioTherapeutics Holdings Inc [SONN]: Institutional Ownership
There are presently around $0.20%, or 0.20%% of SONN stock, in the hands of institutional investors.
